What Researchers Did
Researchers conducted a prospective trial where 35 healthy adults aged 64 and older received 60 daily hyperbaric oxygen therapy (HBOT) sessions, with whole blood samples collected at multiple time points for gene expression analysis.
What They Found
After 60 HBOT sessions, 1912 genes showed differential expression compared to baseline, with 1342 genes upregulated and 570 genes downregulated (p < 0.01 FDR). Specifically, five genes were downregulated by more than 1.5-fold, and ABCA13 remained significantly downregulated by 1.54-fold two weeks post-HBOT (p = 0.008).
What This Means for Canadian Patients
While these findings are preliminary, they suggest that hyperbaric oxygen therapy may influence cellular processes related to aging at a genetic level. Further research is needed to understand if these gene changes translate into tangible health benefits or risks for Canadian patients.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian participants or researchers.
Study Limitations
The study's primary limitation is that it focused solely on gene expression changes, without evaluating clinical outcomes or long-term health impacts of these genetic alterations.